Global Drug Discovery Services Market is expected to reach USD 18.15 Billion by 2026 from USD XX Billion in 2019 at CAGR of XX%.The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.To know about the Research Methodology :- Request Free Sample ReportIncreasing research & development expenditure, increasing patient pool, unmet medical needs, patent expiration of blockbuster drugs, enhancing regulatory framework, government assistance, rising funding & reimbursement, increasing demand for outsourcing of analytical testing and clinical trial services, inclination of major pharmaceutical companies towards outsourcing to avoid hurdles, growing awareness about chronic diseases, is driving the drug discovery services market.Process segment of drug discovery services is segmented into target selection, target validation, and hit-to-lead identification. Hit-To-Lead identification is anticipated to lead maximum share. Research based on the high-throughput screening (HTS) is the main factor driving the use of hit-to-lead identification processMedicinal chemistry, biology services, and drug metabolism and pharmacokinetics. Medicinal chemistry segment is expected to dominate the market during the forecast period, owing to increasing number of drug discovery and developmental activities, and increasing inclination of pharmaceutical companies towards outsourcing.Drug type segment is bifurcated as small molecules and biologics. Small molecules are more preferred than biologics. Small molecules are easy to characterize, simple and well defined. Small molecules can easily enter cells, and can cause cancer cells to die hence is leading drug discovery services market.Geographically, North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America. North America is expected to dominate the drug discovery services market in the forecast period followed by Europe and the Asia Pacific. Technologically advanced research platforms existence and early adoption of highly developed technologies and a supportive economic structure will fuel the drug discovery services market in the North America region.Scope of the Drug Discovery Services Market: Inquire before buyingDrug Discovery Services Market, By Process:• Target Selection• Target Validation• Hit-To-Lead Identification• Lead Optimization• Candidate ValidationDrug Discovery Services Market, By Therapeutic Area:• Oncology• Neurology• Cardiovascular Diseases• Respiratory Disorders• Diabetes• Other Therapeutic AreasDrug Discovery Services Market, By Drug Type:• Small Molecules• BiologicsDrug Discovery Services Market, By Type:• Medicinal Chemistry• Biology Services• Drug Metabolism and Pharmacokinetics (DMPK)Drug Discovery Services Market, By Geography:• North America• Europe• Asia Pacific• Middle East & Africa• Latin AmericaKey Players in the Drug Discovery Services Market:• GE Healthcare• Albany Molecular Research, Inc. (AMRI)• Pharmaceutical Product Development, LLC. (Ppd)• Syngene• Wuxi Apptec• Galapagos NV• Aurigene Discovery Technologies• Genscript Biotech Corporation• WIL Research Laboratories LLC• Covance• Jubilant Biosys• Evotec• Charles River Laboratories International• Merck• Thermo Fisher Scientific• Eurofins Scientific• GVK Biosciences Private Limited• Laboratory Corporation of America Holdings • Lonza Group AG• Piramal Enterprises Ltd.For a More Information Visit @: https://www.maximizemarketresearch.com/market-report/global-drug-di... Report Is Submitted By: Maximize Market Research CompanyCustomization of the report:Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.                                                                   About Maximize Market Research:Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.